NT Mobile Menu

Search form


Alzheimer diseases

Alzheimer diseases

As biomarkers to detect signals of Alzheimer disease improve at providing clinically meaningful information, a majority of Alzheimer researchers support disclosing results to research subjects who have these tests.

PET images show why education can help people cope with the effects of Alzheimer’s disease in its early stages.

Researchers have devoted themselves to devising ways of blocking the production or accumulation of beta-amyloid. Now scientists are studying other protein targets, including tau.

If drugs could be developed to target tau, they might prevent much of the neurodegeneration that characterizes Alzheimer disease and help prevent or delay dementia.


Subscribe to Alzheimer diseases on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.